Satellos Bioscience Inc. (TSX:MSCL)

Satellos Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.3	40.07	16.71	1.42	3.85	0.56
Short-Term Investments	15.31	8.48	13.27	-	-	-
Cash & Short-Term Investments	34.61	48.55	29.98	1.42	3.85	0.56
Cash Growth	99.65%	61.96%	2008.62%	-63.07%	583.57%	83.00%
Other Receivables	0.21	0.44	0.44	0.19	0.42	0.32
Receivables	0.21	0.44	0.44	0.19	0.42	0.32
Prepaid Expenses	0.4	1.76	0.11	0.03	0.03	0
Other Current Assets	2.28	-	0	0	-	-
Total Current Assets	37.5	50.74	30.53	1.65	4.3	0.89
Property, Plant & Equipment	0.01	0	0.01	0.01	0.01	0
Long-Term Investments	-	-	0.03	0.03	-	-
Other Intangible Assets	-	-	2.97	2.89	5.64	-
Total Assets	37.5	50.75	33.54	4.58	9.95	0.89
Accounts Payable	1.39	2.06	0.79	1.08	0.89	0.1
Accrued Expenses	2	1.52	1.96	1.01	0.77	0.07
Total Current Liabilities	3.5	3.58	2.74	2.09	1.66	0.17
Long-Term Debt	-	-	-	-	-	0.86
Total Liabilities	3.5	3.58	2.74	2.09	1.66	1.03
Common Stock	85.55	73.48	46.88	22.32	22.38	3.42
Additional Paid-In Capital	9.32	7.18	6.44	2.72	0.98	0.19
Retained Earnings	-74.67	-52.54	-35.97	-23.36	-16.03	-3.76
Comprehensive Income & Other	13.81	19.05	13.45	0.8	0.97	-
Shareholders' Equity	34	47.16	30.8	2.49	8.28	-0.14
Total Liabilities & Equity	37.5	50.75	33.54	4.58	9.95	0.89
Total Debt	-	-	-	-	-	0.86
Net Cash (Debt)	34.61	48.55	29.98	1.42	3.85	-0.29
Net Cash Growth	99.65%	61.96%	2008.62%	-63.07%	-	-
Net Cash Per Share	0.22	0.42	0.35	0.04	0.16	-0.02
Filing Date Shares Outstanding	185.51	165.82	112.79	41.8	33	12.09
Total Common Shares Outstanding	185.09	165.82	112.79	41.8	33	12.09
Working Capital	33.99	47.16	27.79	-0.44	2.64	0.71
Book Value Per Share	0.18	0.28	0.27	0.06	0.25	-0.01
Tangible Book Value	34	47.16	27.83	-0.4	2.64	-0.14
Tangible Book Value Per Share	0.18	0.28	0.25	-0.01	0.08	-0.01
Machinery	-	-	-	0.01	0.01	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.